Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2012 1
2013 1
2017 1
2018 1
2020 4
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Trends and Cost of Heart Transplantation and Left Ventricular Assist Devices: Impact of Proposed Federal Cuts.
Patel N, Kalra R, Doshi R, Bajaj NS, Arora G, Arora P. Patel N, et al. JACC Heart Fail. 2018 May;6(5):424-432. doi: 10.1016/j.jchf.2018.03.005. JACC Heart Fail. 2018. PMID: 29724365 Free article.
OBJECTIVES: The purpose of this study was to compare trends of use, in-hospital mortality, and annual expenditures associated with orthotopic heart transplantation (OHT) and left ventricular assist device (LVAD) implantation. In view of the changing health ca …
OBJECTIVES: The purpose of this study was to compare trends of use, in-hospital mortality, and annual expenditures associated with orthotopi …
Disparities and Impact of Medicaid Expansion on Left Ventricular Assist Device Implantation and Outcomes.
Wang X, Luke AA, Vader JM, Maddox TM, Joynt Maddox KE. Wang X, et al. Circ Cardiovasc Qual Outcomes. 2020 Jun;13(6):e006284. doi: 10.1161/CIRCOUTCOMES.119.006284. Epub 2020 May 12. Circ Cardiovasc Qual Outcomes. 2020. PMID: 32394720 Free PMC article.
BACKGROUND: Left ventricular assist device (LVAD) therapy is an increasingly viable alternative for patients who are not candidates for heart transplantation or who are waiting for a suitable donor. ...METHODS AND RESULTS: Retrospective cohort study using Sta …
BACKGROUND: Left ventricular assist device (LVAD) therapy is an increasingly viable alternative for patients who are no …
Percutaneous Ventricular Assist Device vs. Intra-Aortic Balloon Pump for Hemodynamic Support in Acute Myocardial Infarction-Related Cardiogenic Shock and Coexistent Atrial Fibrillation: A Nationwide Propensity-Matched Analysis'.
Desai R, Hanna B, Singh S, Gupta S, Deshmukh A, Kumar G, Sachdeva R, Berman AE. Desai R, et al. Am J Med Sci. 2021 Jan;361(1):55-62. doi: 10.1016/j.amjms.2020.08.018. Epub 2020 Aug 12. Am J Med Sci. 2021. PMID: 33008567
BACKGROUND: Patients suffering an acute myocardial infarction complicated by cardiogenic shock (AMICS) may experience clinical deterioration with concomitant atrial fibrillation (AF). Recent data suggest that percutaneous ventricular assist devices (pVADs) pr …
BACKGROUND: Patients suffering an acute myocardial infarction complicated by cardiogenic shock (AMICS) may experience clinical deterioration …
Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries.
Hernandez AF, Shea AM, Milano CA, Rogers JG, Hammill BG, O'Connor CM, Schulman KA, Peterson ED, Curtis LH. Hernandez AF, et al. JAMA. 2008 Nov 26;300(20):2398-406. doi: 10.1001/jama.2008.716. JAMA. 2008. PMID: 19033590 Free PMC article.
Patients were Medicare fee-for-service beneficiaries who received a ventricular assist device between February 2000 and June 2006 alone as primary therapy (primary device group; n = 1476) or after cardiotomy in the previous 30 days (postcardioto …
Patients were Medicare fee-for-service beneficiaries who received a ventricular assist device between February 2 …
Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.
Mulloy DP, Bhamidipati CM, Stone ML, Ailawadi G, Kron IL, Kern JA. Mulloy DP, et al. J Thorac Cardiovasc Surg. 2013 Feb;145(2):566-73; discussion 573-4. doi: 10.1016/j.jtcvs.2012.10.034. Epub 2012 Dec 13. J Thorac Cardiovasc Surg. 2013. PMID: 23246055 Free PMC article.
RESULTS: The incidence of orthotopic heart transplantation increased marginally within a 5-year period. In contrast, the annual left ventricular assist device implantation rates nearly tripled. In-hospital mortality from left ventricular assist
RESULTS: The incidence of orthotopic heart transplantation increased marginally within a 5-year period. In contrast, the annual left vent
Gender Differences in the Outcomes of Cardiogenic Shock Requiring Percutaneous Mechanical Circulatory Support.
Bravo-Jaimes K, Mejia MO, Abelhad NI, Zhou Y, Jumean MF, Nathan S, Dhoble A. Bravo-Jaimes K, et al. Am J Cardiol. 2022 Jul 1;174:20-26. doi: 10.1016/j.amjcard.2022.03.033. Epub 2022 Apr 24. Am J Cardiol. 2022. PMID: 35469654
We aimed to determine (1) whether gender differences exist regarding in-hospital mortality, hospital course, and procedures; (2) whether socio-demographic and treatment-related factors were associated with these differences. Using the National Inpatient Sample, we collecte …
We aimed to determine (1) whether gender differences exist regarding in-hospital mortality, hospital course, and procedures; (2) whether soc …
Sociodemographic differences in utilization and outcomes for temporary cardiovascular mechanical support in the setting of cardiogenic shock.
Thangam M, Luke AA, Johnson DY, Amin AP, Lasala J, Huang K, Joynt Maddox KE. Thangam M, et al. Am Heart J. 2021 Jun;236:87-96. doi: 10.1016/j.ahj.2020.12.014. Epub 2021 Feb 26. Am Heart J. 2021. PMID: 33359779
METHODS: Retrospective cross-sectional study using the National Inpatient Sample for 2012-2017. Logistic regression models were used to examine predictors of use of temporary MCS devices and for in-hospital mortality, clustering by hospital-year. ...Overall, 14.3% o …
METHODS: Retrospective cross-sectional study using the National Inpatient Sample for 2012-2017. Logistic regression models were used …
Cost savings for pVAD compared to ECMO in the management of acute myocardial infarction complicated by cardiogenic shock: An episode-of-care analysis.
Vetrovec GW, Lim MJ, Needham KA. Vetrovec GW, et al. Catheter Cardiovasc Interv. 2021 Oct;98(4):703-710. doi: 10.1002/ccd.29181. Epub 2020 Aug 13. Catheter Cardiovasc Interv. 2021. PMID: 32790231
BACKGROUND: Acute myocardial infarction complicated by cardiogenic shock (AMICS) occurs in up to 10% of acute myocardial infarction admissions and is associated with high mortality, frequent adverse outcomes, prolonged hospitalizations, extensive medical resource utilizati …
BACKGROUND: Acute myocardial infarction complicated by cardiogenic shock (AMICS) occurs in up to 10% of acute myocardial infarction admissio …
Outcomes of catheter ablation of ventricular tachycardia with mechanical hemodynamic support: An analysis of the Medicare database.
Aryana A, d'Avila A, Cool CL, Miller MA, Garcia FC, Supple GE, Dukkipati SR, Lakkireddy D, Bunch TJ, Bowers MR, O'Neill PG, Reddy VY, Marchlinski FE. Aryana A, et al. J Cardiovasc Electrophysiol. 2017 Nov;28(11):1295-1302. doi: 10.1111/jce.13312. Epub 2017 Sep 1. J Cardiovasc Electrophysiol. 2017. PMID: 28800178
INTRODUCTION: There is a paucity of data in favor of mechanical support during catheter ablation of ventricular tachycardia (VT). This study investigated the outcomes of VT ablation associated with mechanical support using percutaneous ventricular assist d
INTRODUCTION: There is a paucity of data in favor of mechanical support during catheter ablation of ventricular tachycardia (VT). Thi …
Regional Variation in the Management and Outcomes of Acute Myocardial Infarction With Cardiogenic Shock in the United States.
Vallabhajosyula S, Patlolla SH, Dunlay SM, Prasad A, Bell MR, Jaffe AS, Gersh BJ, Rihal CS, Holmes DR Jr, Barsness GW. Vallabhajosyula S, et al. Circ Heart Fail. 2020 Feb;13(2):e006661. doi: 10.1161/CIRCHEARTFAILURE.119.006661. Epub 2020 Feb 14. Circ Heart Fail. 2020. PMID: 32059628 Free PMC article.
BACKGROUND: There are few studies evaluating regional disparities in the care of acute myocardial infarction-cardiogenic shock (AMI-CS). METHODS AND RESULTS: Using the National Inpatient Sample from 2000 to 2016, we identified adults with a primary diagnosis of AMI and con …
BACKGROUND: There are few studies evaluating regional disparities in the care of acute myocardial infarction-cardiogenic shock (AMI-CS). MET …